DeVinney Erick Wayne
Chief Innovation Officer at AXGN
- Sold, on record
- $1.1M
- Dollars the filings state
- Form 4 sales
- 7
- Latest Mar 16, 2026
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- AXGNAxogen, Inc.Chief Innovation Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale AXGNPlan not statedDec 21, 2020 2020
Sold 147 shares at $16.42 ($2k)
DeVinney Erick Wayne, VP, Clinical&Translational Sc
Sold 0.2% of holdings ($1M position)62,111 shares leftFirst sale on recordFiling
- 2 Form 4 sale AXGNPlan not statedDec 29, 2020 +8 days
Sold 371 shares at $17.81 ($7k)
DeVinney Erick Wayne, VP, Clinical&Translational Sc
Sold 0.6% of holdings ($1.1M position)63,240 shares leftFiling
- 3 Form 4 sale AXGNNo planMar 21, 2024 +1178 days
Sold 4,578 shares at $7.68 ($35k)
DeVinney Erick Wayne, Chief Innovation Officer
No 10b5-1 planSold 2.5% of holdings ($1.4M position)177,474 shares leftFirst sale on recordFiling
- 4 Form 4 sale AXGNNo planMar 19, 2025 +363 days
Sold 15,111 shares at $17.50 ($264k)
DeVinney Erick Wayne, Chief Innovation Officer
No 10b5-1 planSold 6.5% of holdings ($4.1M position)217,762 shares leftFiling
- 5 Form 4 sale AXGNNo planSep 16, 2025 +181 days
Sold 1,137 shares at $16.29 ($19k)
DeVinney Erick Wayne, Chief Innovation Officer
No 10b5-1 planSold 0.5% of holdings ($3.6M position)220,649 shares leftFiling
- 6 Form 4 sale AXGNUnusualDec 9, 2025 +84 days
Sold 19,517 shares at $31.21 ($609k)
DeVinney Erick Wayne, Chief Innovation Officer
No 10b5-1 planSold 7.5% of holdings ($8.1M position)241,132 shares left4.3x usual sizeFiling
- 7 Form 4 sale AXGNNo planMar 16, 2026 +97 days
Sold 5,221 shares at $32.84 ($171k)
DeVinney Erick Wayne, Chief Innovation Officer
No 10b5-1 planSold 1.9% of holdings ($8.8M position)262,781 shares left0.5x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Mar 18, 2026 | AXGN | Chief Innovation Officer | Form 4 sale | 5,221 | $171k | 1.9% | No plan | SEC |
| Dec 9, 2025 | Dec 10, 2025 | AXGN | Chief Innovation Officer | Form 4 sale | 19,517 | $609k | 7.5% | Unusual | SEC |
| Sep 16, 2025 | Sep 16, 2025 | AXGN | Chief Innovation Officer | Form 4 sale | 1,137 | $19k | 0.5% | No plan | SEC |
| Mar 19, 2025 | Mar 19, 2025 | AXGN | Chief Innovation Officer | Form 4 sale | 15,111 | $264k | 6.5% | No plan | SEC |
| Mar 21, 2024 | Mar 25, 2024 | AXGN | Chief Innovation Officer | Form 4 sale | 4,578 | $35k | 2.5% | No plan | SEC |
| Dec 29, 2020 | Dec 30, 2020 | AXGN | VP, Clinical&Translational Sc | Form 4 sale | 371 | $7k | 0.6% | Plan not stated | SEC |
| Dec 21, 2020 | Dec 22, 2020 | AXGN | VP, Clinical&Translational Sc | Form 4 sale | 147 | $2k | 0.2% | Plan not stated | SEC |